TEVA PHARMACEUTICAL INDUSTRIES LIMITED Business Acquisition, Pro Forma Revenue
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Business Acquisition, Pro Forma Revenue of $17.40 billion for the 12-month period ending 2010-12-31, per its 20-F filed 2013-02-12.
Discontinued › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2013-02-12
| Period end | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|
| 2010-12-31 | $17.40B 20-F · filed 2013-02-12 |